IP Library Granted Patent US 10,182,992
Granted Patent B2
US 10,182,992 · App. 14/679,062 · Granted Jan 22, 2019

Abuse-deterrent controlled release formulations

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,182,992
App. No.
14/679,062
Granted
Jan 22, 2019
Kind
B2
Abstract

Described herein are abuse deterrent controlled release oral pharmaceutical compositions comprising and methods for making the same. In particular, an abuse deterrent controlled release oral pharmaceutical composition comprising a soft capsule and an abuse deterrent controlled release matrix comprising an active pharmaceutical ingredient are described.

Claims (26)

1. An abuse deterrent tamper resistant oral pharmaceutical dosage form comprising a soft capsule shell encapsulating a tamper resistant matrix comprising:

(a) about 45% to about 52% by mass soybean oil;

(b) about 1.8% to about 4% by mass polyethylene glycol glyceride ester;

(c) about 1.8% to about 4% by mass bee's wax;

(d) about 5% to about 15% by mass of a polyethylene oxide having a molecular weight of about 100,000;

(e) about 0.5% to about 4% by mass carboxypolymethylene;

(f) about 2% to about 8% by mass dimethylaminoethyl methacrylate copolymer;

(g) about 0.5% to about 5% by mass fumed silica; and

(h) about 5% to about 30% by mass tapentadol hydrochloride.

2. An abuse deterrent oral pharmaceutical dosage form comprising a soft capsule shell encapsulating a tamper resistant matrix comprising:

(a) about 45% to about 52% by mass soybean oil;

(b) about 1.5% to about 5% by mass polyethylene glycol glyceride ester;

(c) about 1.8% to about 4% by mass bee's wax;

(d) about 2% to about 8% by mass polyvinylpyrrolidone 90 ;

(e) about 0.5% to about 4% by mass carbomer polymer;

(f) about 2% to about 8% by mass dimethylaminoethyl methacrylate copolymer;

(g) about 0.5% to about 5% by mass fumed silica; and

(h) about 5% to about 30% by mass tapentadol hydrochloride.

3. The composition of claim 1 , wherein the soft capsule shell comprises:

(a) about 25-50% by mass of at least one film-forming polymer;

(b) about 15-25% by mass of at least one plasticizer; and

(c) about 20-40% by mass of a solvent.

4. The composition of claim 2 , wherein the soft capsule shell comprises:

(a) about 25-50% by mass of at least one film-forming polymer;

(b) about 15-25% by mass of at least one plasticizer; and

(c) about 20-40% by mass of a solvent.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION NUMBER: 62250248 PREVIOUSLY RECORDED ON REEL 046622 FRAME 0054. ASSIGNOR(S) HEREBY CONFIRMS THE APPLICATION NUMBER: 62250284. Recorded Dec 6, 2018
From: BANNER LIFE SCIENCES LLC
To: PATHEON SOFTGELS INC.
Reel/Frame 047733/0544 →
NUNC PRO TUNC ASSIGNMENT Recorded Aug 13, 2018
From: BANNER LIFE SCIENCES LLC
To: PATHEON SOFTGELS INC.
Reel/Frame 046622/0054 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2015
From: VAMVAKAS, GEORGE; FATMI, AQEEL
To: BANNER LIFE SCIENCES LLC
Reel/Frame 035360/0517 →